Dihydrokavain

Dihydrokavain is a kavalactone, a class of lactone compounds found in the kava plant. It is one of six major kavalactones, which are primarily responsible for the psychoactive and physiological effects of kava. Dihydrokavain is known for its anxiolytic and analgesic properties, and it contributes to the overall calming effect of kava.
Chemistry[edit]
Dihydrokavain is a chiral molecule, with two possible enantiomers due to its single stereogenic center. It is a member of the class of compounds known as benzodihydropyrans. Its chemical formula is C14H16O3.
Pharmacology[edit]
Dihydrokavain acts on the central nervous system, primarily affecting the GABA (gamma-aminobutyric acid) receptors. It is thought to enhance the effects of GABA, leading to an overall reduction in neuronal excitability. This results in the anxiolytic and sedative effects associated with kava.
Effects[edit]
The effects of dihydrokavain are primarily sedative and anxiolytic. It is known to induce a state of relaxation, without the loss of mental clarity. In higher doses, it can cause mild euphoria and alterations in perception.
Safety[edit]
While kava and its kavalactones, including dihydrokavain, have been used safely for centuries in traditional Pacific Island cultures, there are some concerns about potential liver toxicity with long-term use. However, these risks appear to be low and may be related to other factors such as alcohol consumption or the use of other medications.
See also[edit]

This analgesic-related article is a stub. You can help WikiMD by expanding it.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
